Afala tablets for resorption,

Afala tab.

d / rass.

No. 100

Name ENG

AFALA

Clinical and pharmacological group

Drug for the treatment of benign prostatic hyperplasia

ATX code

Other drugs for the treatment of benign prostatic hyperplasia

Dosage

3mg

Structure

Active substances: antibodies to prostate-specific antigen affinity purified - 0.003 g *. Excipients: lactose, microcrystalline cellulose, magnesium stearate.

* introduced in the form of a water-alcohol mixture of the active form of the active substance

Indications

Benign prostatic hyperplasia of the I and II stages.

As part of the complex therapy of acute and chronic prostatitis - as an anti-inflammatory and analgesic agent.

Dysuric disorders (frequent urge to urinate, including at night, difficulty urinating, pain or discomfort in the perineal region), including those accompanying benign prostatic hyperplasia of I and II stages

acute and chronic prostatitis.

Storage conditions and periods

At a temperature not higher than 25 degrees.

Expiration date: 3 years

Contraindications

Increased individual sensitivity to drug components.

Not recommended for use in patients under the age of 18 due to insufficient data on efficacy and safety for this age.

Lactase deficiency, lactose intolerance, glucose-galactose malabsorption.

INN / Active ingredient

Antibodies to prostate-specific antigen affinity purified

Specifications

Category

BPH

,

Impotence in men

Scope of the drug

Genitourinary system

Release form

Tablet

Manufacturer country

Russia

Package quantity, pcs

one hundred

Scope of application

Urology

Way of introduction

Through the mouth

Vacation conditions

Without recipe

Brand name

Materia Medica Holding

The amount of the dosage form in the primary package

20 pcs.

Primary packaging type

Blister

Type of consumer packaging

Pack of cardboard

Pharmaco-therapeutic group

Prostate hyperplasia benign remedy

Dosage form

Lozenges

Expiration date in days

1095

Package weight, g

ten

Mode of application

:

Inside.

< br> At one time 2 tablets (keep in mouth until completely dissolved - not during meals).

< br> Take the drug 2 times / day, in the evening and in the morning (before and after sleep).

The recommended duration of taking the drug is 16 weeks.

< br> With severe pain syndrome and dysuric disorders in the first 2-3 weeks of therapy, taking the drug up to 4 times / day is indicated.

< br> If necessary, on the recommendation of a doctor, it is possible to repeat the course of treatment in 1-4 months.

Anatomical and therapeutic characteristics

:

G04CX Drugs for the treatment of benign prostatic hypertrophy other

Dosage (volume) of the substance in the preparation

:

Affinity purified antibodies to prostate-specific antigen - 0.003 g